Flolan IV 1.5mg, manufactured by GlaxoSmithKline, contains Epoprostenol sodium, a prostacyclin vasodilator. It is indicated for the long-term intravenous treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity. YJ code: 2190413F4027, standard: 1.5mg 1 bottle (with solution).
Flolan IV 1.5mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).